EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3

Yanghao Chen, Bozhi Ye, Diyun Xu, Wante Lin, Zimin Fang, Xuefeng Qu, Xue Han, Wu Luo, Chen Chen, Weijian Huang, Hao Zhou, Gaojun Wu und 2 weitere

Acta Pharmaceutica Sinica B · 2025-03 · 15 (3) · 1643-1658

DOI: 10.1016/j.apsb.2024.12.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-03. Verfasst von Yanghao Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and the Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Wenz…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term hypertension causes excessive vascular remodeling and leads to adverse cardiovascular events. Balance of ubiquitination and deubiquitination has been linked to several chronic conditions, including pathological vascular remodeling. In this study, we discovered that the expression of ubiquitin-specific protease 25 (USP25) is significantly up-regulated in angiotensin II (Ang II)-challenged mouse aorta. Knockout of Usp25 augments Ang II-induced vascular injury such as fibrosis and endothelial to mesenchymal transition (EndMT). Mechanistically, we found that USP25 interacts directly with Forkhead box O3 (FOXO3) and removes the K63-linked ubiquitin chain on the K258 site of FOXO3. We also showed that this USP25-mediated deubiquitination of FOXO3 increases its binding to light chain 3 beta isoform and autophagosomic-lysosomal degradation of FOXO3. In addition, we further validated the biological function of USP25 by overexpressing USP25 in the mouse aorta with AAV9 vectors. Our studies identified FOXO3 as a new substrate of USP25 and showed that USP25 may be a potential therapeutic target for excessive vascular remodeling-associated diseases.

Schlagwörter

Stichwörter der Autor:innen

Angiotensin IIAutolysosomeDeubiquitinaseEndothelial-to-mesenchymal transitionFOXO3LC3BUSP25Vascular remodeling

Autor:innen und Institutionen

  • Department of Cardiology and the Key Laboratory of Cardiovascular Disease of Wenzhou, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China.
  • Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  • School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou 310059, China.
  • School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.

Förderung

  • Zhejiang Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Chen, Y., Ye, B., Xu, D., Lin, W., Fang, Z., Qu, X., Han, X., Luo, W., Chen, C., Huang, W., Zhou, H., Wu, G., Wang, Y., & Liang, G. (2025). USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3. Acta Pharmaceutica Sinica B, 15(3), 1643-1658. https://doi.org/10.1016/j.apsb.2024.12.033

Vancouver

Chen Y, Ye B, Xu D, Lin W, Fang Z, Qu X, et al. USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3. Acta Pharmaceutica Sinica B. 2025;15(3):1643-1658. doi:10.1016/j.apsb.2024.12.033

BibTeX
@article{Chen2025,
  author = {Chen, Yanghao and Ye, Bozhi and Xu, Diyun and Lin, Wante and Fang, Zimin and Qu, Xuefeng and Han, Xue and Luo, Wu and Chen, Chen and Huang, Weijian and Zhou, Hao and Wu, Gaojun and Wang, Yi and Liang, Guang},
  title = {USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {1643--1658},
  doi = {10.1016/j.apsb.2024.12.033}
}
Kostenlos starten →